Peptonic Medical Expands Product Line and US Market Presence
Peptonic Medical AB is updating on its product development and the commercial progress of its partnership with US-based Joylux Inc. The company plans to introduce new products, including its first dietary supplement, this autumn.
Peptonic Medical AB has provided an update on its product development and the commercial progress of its partnership with US-based Joylux Inc. The company is also focused on broadening its VagiVital offering within women's health and well-being. Several new products are scheduled for introduction this autumn, including the company's first dietary supplement.
The partnership with Joylux in the North American market continues to develop. Peptonic stated that the collaboration with its US partner has shown commercial progress, though specific financial details were not disclosed.
This autumn will see the launch of multiple new products from Peptonic Medical. Among these is the company's inaugural dietary supplement, signifying an expansion of its product portfolio beyond existing offerings. Exact launch dates for these new items were not provided.
Throughout 2026, Peptonic Medical has focused on expanding its product portfolio and strengthening VagiVital's market position. The objective is to establish a more robust and comprehensive presence in the women's health and well-being sector.